A Paradigm Shift: CAR T-Cell Therapy Offers New Hope for Stiff Person Syndrome
Kyverna's KYV-101: A Glimmer of Hope for Lupus Nephritis Patients with Early, Deep Responses, Yet Caution Remains
Kyverna Therapeutics: Charting a Course for Revolutionary Autoimmune CAR T Therapy by 2026